HSP90AA1 and non-small cell lung carcinoma: Moreover, consistent with previous reports suggesting an association of Hsp90 with anticancer drug resistance and overcoming the resistance to chemo- or targeted anticancer therapies by using Hsp90 inhibitors54–57, NCT-50 was effective in both chemo-naïve and chemoresistant NSCLC cells..